Is Bombay Super Hyb overvalued or undervalued?

As of 26 September 2025, the valuation grade for Bombay Super Hyb has moved from very expensive to expensive. The company is currently considered overvalued based on its high valuation metrics. The PE ratio stands at 50.07, while the EV to EBITDA ratio is 42.66, and the PEG ratio is 2.34, indicating that the stock is trading at a premium compared to its earnings growth potential.
In comparison to its peers, Jain Irrigation has a PE ratio of 110.1 and an EV to EBITDA of 10.31, while Indo US Bio-Tech is more reasonably valued with a PE of 14.77 and an EV to EBITDA of 13.39. This suggests that Bombay Super Hyb's valuation is significantly higher than some of its peers, reinforcing the conclusion of being overvalued. Additionally, the company's stock has underperformed relative to the Sensex over the past year, with a return of -24.22% compared to the Sensex's -5.96%, further supporting the notion that the current valuation may not be justified.